Haploid Human Embryonic Stem Cells: Half the Genome, Double the Value

Atilgan Yilmaz, Mordecai Peretz, Ido Sagi*, Nissim Benvenisty

*Corresponding author for this work

Research output: Contribution to journalComment/debate

25 Scopus citations


Recent advances in the generation of haploid embryonic stem cells (ESCs), capable of self-renewal and differentiation, have laid the groundwork for numerous biomedical applications in developmental biology and reproductive medicine. When combined with the power of genetic screening, haploid human ESCs could advance cancer research, regenerative medicine, and disease modeling.

Original languageAmerican English
Pages (from-to)569-572
Number of pages4
JournalCell Stem Cell
Issue number5
StatePublished - 3 Nov 2016

Bibliographical note

Funding Information:
A.Y. is supported by the Lady Davis Postdoctoral Fellowship , I.S. is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities , and N.B. is the Herbert Cohn Chair in Cancer Research . This work was partially supported by The Azrieli Foundation .

Publisher Copyright:
© 2016 Elsevier Inc.


Dive into the research topics of 'Haploid Human Embryonic Stem Cells: Half the Genome, Double the Value'. Together they form a unique fingerprint.

Cite this